Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Medicine and Surgery"
DOI: 10.1097/ms9.0000000000000113
Abstract: One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and… read more here.
Keywords: blind spot; revisiting blind; spot substandard; antimicrobial resistance ... See more keywords